H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 1, 2008, Pages

  Pan, Ting Ting ^a   Neo, Kay Li ^a   Hu, Li Fang ^a   Yong, Qian Chen ^a   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

ATP sensitive potassium channel; Cardioprotection; Ischemia and reperfusion; Protein kinase C isoforms

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CAFFEINE; CALCIUM; GLIBENCLAMIDE; HYDROGEN SULFIDE; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; ALKALOID; BENZOPHENANTHRIDINE DERIVATIVE; CHELERYTHRINE; PROTEIN KINASE C EPSILON; PROTEIN KINASE INHIBITOR; SODIUM BISULFIDE; SULFIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOBLOTTING; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; CELL SIZE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; ENZYMOLOGY; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PROTEIN TRANSPORT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME;

RATTUS;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CAFFEINE; CALCIUM; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; ELECTRIC STIMULATION; ENZYME ACTIVATION; GLYBURIDE; KATP CHANNELS; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; POTASSIUM CHANNEL BLOCKERS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RESEARCH DESIGN; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SODIUM-CALCIUM EXCHANGER; SULFIDES; TIME FACTORS;

EID: 38349104238     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00282.2007     Document Type: Article

References (32)

1. Abdallah Y, Gkatzoflia A, Pieper H, Zoga E, Walther S, Kasseckert S, Schafer M, Schluter KD, Piper HM, Schafer C. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66: 123-131, 2005.
2. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87: 275-281, 2000.
3. Bian JS, Wang HX, Zhang WM, Wong TM. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C. Br J Pharmacol 124: 600-606, 1998.
4. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: 670-678, 2006.
5. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol Cell Physiol 245: C1-C14, 1983.
6. Ganote CE. Contraction band necrosis and irreversible myocardial injury. J Mol Cell Cardiol 15: 67-73, 1983.
7. Guatimosim S, Dilly K, Santana LF, Saleet Jafri M, Sobie EA, Lederer WJ. Local Ca(2+) signaling and EC coupling in heart: Ca(2+) sparks and the regulation of the [Ca(2+)](i) transient. J Mol Cell Cardiol 34: 941-950, 2002.
8. Hassouna A, Matata BM, Galinanes M. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 287: C1418-C1425, 2004.
9. Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocates PKC-delta and -epsilon, which mediate functional protection in isolated rat heart. Am J Physiol Heart Circ Physiol 275: H2266-H2271, 1998.
10. Ladilov YV, Balser C, Piper HM. Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator. Circ Res 82: 451-457, 1998.
11. Mackay K, Mochly-Rosen D. Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc Res 50: 65-74, 2001.
12. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol 33: 1301-1307, 2001.
13. Matsumura K, Komori S, Takusagawa M, Osada M, Tanabe F, Itoh M, Tamura K. Protein kinase C is involved in cardioprotective effects of ischemic preconditioning on infarct size and ventricular arrhythmia in rats in vivo. Mol Cell Biochem 214: 39-45, 2000.
14. Miyawaki H, Ashraf M. Ca2+ as a mediator of ischemic preconditioning. Circ Res 80: 790-799, 1997.
15. Moon CH, Jung YS, Lee SH, Baik EJ. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn J Physiol 49: 409-415, 1999.
16. Morris SD, Cumming DV, Latchman DS, Yellon DM. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression? J Clin Invest 97: 706-712, 1996.
17. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 40: 119-130, 2006.
18. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, Banerjee S, Dawn B, Balafonova Z, Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 84: 587-604, 1999.
19. Piper HM, Siegmund B, Ladilov Yu V, Schluter KD. Calcium and sodium control in hypoxic-reoxygenated cardiomyocytes. Basic Res Cardiol 88: 471-482, 1993.
20. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 74: 299-309, 1994.
21. Sanada S, Kitakaze M. Ischemic preconditioning: emerging evidence, controversy, and translational trials. Int J Cardiol 97: 263-276, 2004.
22. Sham JS, Hatem SN, Morad M. Species differences in the activity of the Na(+)-Ca2+ exchanger in mammalian cardiac myocytes. J Physiol 488: 623-631, 1995.
23. Siegmund B, Schluter KD, Piper HM. Calcium and the oxygen paradox. Cardiovasc Res 27: 1778-1783, 1993.
24. Speechly-Dick ME, Mocanu MM, Yellon Protein kinase CDM. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
25. Stamm C, del Nido PJ. Protein kinase C and myocardial calcium handling during ischemia and reperfusion: lessons learned using Rhod-2 spectrofluorometry. Thorac Cardiovasc Surg 52: 127-134, 2004.
26. Stamm C, Friehs I, Cowan DB, Cao-Danh H, Noria S, Munakata M, McGowan FX Jr, del Nido PJ. Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity. Cardiovasc Res 51: 108-121, 2001.
27. Tang G, Wu L, Liang W, Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68: 1757-1764, 2005.
28. Toma O, Weber NC, Wolter JI, Obal D, Preckel B, Schlack W. Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology 101: 1372-1380, 2004.
29. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798, 2002.
30. Weber NC, Toma O, Wolter JI, Obal D, Mullenheim J, Preckel B, Schlack W. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 144: 123-132, 2005.
31. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B. Mechanisms of xenon- and isoflurane-induced preconditioning-a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 146: 445-455, 2005.
32. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84: 1388-1395, 1999.